Work

Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer

Year: 2025

Type: erratum

Source: Prostate Cancer and Prostatic Diseases

DOI: 10.1038/s41391-025-01055-7

Authors: Autumn Gagnon, Caiwei Zhong, Wanling Xie, Lynne Morlock, Dory Freeman, Rachel Trowbridge, Kerry L. Kilbridge, Bradley A. McGregor, Mary-Ellen Taplin, Atish D. Choudhury

Institutions: Dana-Farber Cancer Institute, MGH Institute of Health Professions, Harvard University, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416345731

Cites:

Cited by:

Related to: 10